Page 41 - Read Online

Classification of Tumours of the Lung, Pleura, Thymus and Heart. CS, Foo CK, Bhatt D, Stinson J, Gnad F, Haverty PM, Gentleman
4th edition. In. Lyon France: International Agency for Research on R, Chaudhuri S, Janakiraman V, Jaiswal BS, Parikh C, Yuan W,
Cancer; 2015. Zhang Z, Koeppen H, Wu TD, Stern HM, Yauch RL, Huffman KE,
70. Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol Paskulin DD, Illei PB, Varella-Garcia M, Gazdar AF, de Sauvage
2010;21 Suppl 7:vii65-71. FJ, Bourgon R, Minna JD, Brock MV, Seshagiri S. Comprehensive
71. Detterbeck FC. Management of carcinoid tumors. Ann Thorac Surg genomic analysis identifies SOX2 as a frequently amplified gene in
2010;89:998-1005. small-cell lung cancer. Nat Genet 2012;44:1111-6.
72. Besse B, Heist RS, Papadmitrakopoulou VA, Camidge DR, Beck 83. Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozretic L, Seidel D,
JT, Schmid P, Mulatero C, Miller N, Dimitrijevic S, Urva S, Zander T, Leenders F, George J, Muller C, Dahmen I, Pinther B,
Pylvaenaeinen I, Petrovic K, Johnson BE. A phase Ib dose-escalation Bosco G, Konrad K, Altmuller J, Nurnberg P, Achter V, Lang U,
study of everolimus combined with cisplatin and etoposide as first- Schneider PM, Bogus M, Soltermann A, Brustugun OT, Helland
line therapy in patients with extensive-stage small-cell lung cancer. A, Solberg S, Lund-Iversen M, Ansen S, Stoelben E, Wright
Ann Oncol 2014;25:505-11. GM, Russell P, Wainer Z, Solomon B, Field JK, Hyde R, Davies
73. Pavel ME, Hainsworth JD, Baudin E, Peeters M, Horsch D, Winkler MP, Heukamp LC, Petersen I, Perner S, Lovly CM, Cappuzzo F,
RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM, Oberg K, Van Travis WD, Wolf J, Vingron M, Brambilla E, Haas SA, Buettner R,
Cutsem E, Yao JC, Group R-S. Everolimus plus octreotide long-acting Thomas RK. Frequent mutations in chromatin-remodelling genes in
repeatable for the treatment of advanced neuroendocrine tumours pulmonary carcinoids. Nat Commun 2014;5:3518.
associated with carcinoid syndrome (RADIANT-2): a randomised, 84. George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders
placebo-controlled, phase 3 study. Lancet 2011;378:2005-12. F, Lu X, Fernandez-Cuesta L, Bosco G, Muller C, Dahmen I,
74. Han JY, Kim HY, Lim KY, Han JH, Lee YJ, Kwak MH, Kim HJ, Jahchan NS, Park KS, Yang D, Karnezis AN, Vaka D, Torres A,
Yun T, Kim HT, Lee JS. A phase II study of sunitinib in patients Wang MS, Korbel JO, Menon R, Chun SM, Kim D, Wilkerson
with relapsed or refractory small cell lung cancer. Lung Cancer M, Hayes N, Engelmann D, Putzer B, Bos M, Michels S, Vlasic
2013;79:137-42. I, Seidel D, Pinther B, Schaub P, Becker C, Altmuller J, Yokota J,
75. Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman Kohno T, Iwakawa R, Tsuta K, Noguchi M, Muley T, Hoffmann H,
S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Schnabel PA, Petersen I, Chen Y, Soltermann A, Tischler V, Choi
Salgia R, Le Chevalier T. Phase II study of imatinib in patients with CM, Kim YH, Massion PP, Zou Y, Jovanovic D, Kontic M, Wright
small cell lung cancer. Clin Cancer Res 2003;9:5880-7. GM, Russell PA, Solomon B, Koch I, Lindner M, Muscarella LA,
76. Shibata T, Kokubu A, Tsuta K, Hirohashi S. Oncogenic mutation la Torre A, Field JK, Jakopovic M, Knezevic J, Castanos-Velez E,
of PIK3CA in small cell lung carcinoma: a potential therapeutic Roz L, Pastorino U, Brustugun OT, Lund-Iversen M, Thunnissen E,
target pathway for chemotherapy-resistant lung cancer. Cancer Lett Kohler J, Schuler M, Botling J, Sandelin M, Sanchez-Cespedes M,
2009;283:203-11. Salvesen HB, Achter V, Lang U, Bogus M, Schneider PM, Zander
77. Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, T, Ansen S, Hallek M, Wolf J, Vingron M, Yatabe Y, Travis WD,
Mitsudomi T, Yatabe Y. Epidermal growth factor receptor mutations Nurnberg P, Reinhardt C, Perner S, Heukamp L, Buttner R, Haas
in small cell lung cancer. Clin Cancer Res 2008;14:6092-6. SA, Brambilla E, Peifer M, Sage J, Thomas RK. Comprehensive
78. Wistuba, II, Gazdar AF, Minna JD. Molecular genetics of small cell genomic profiles of small cell lung cancer. Nature 2015;524:47-53.
lung carcinoma. Semin Oncol 2001;28:3-13. 85. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L.
79. Wakuda K, Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi S, Molecular characterisation of side population cells with cancer
Ono A, Taira T, Naito T, Murakami H, Mori K, Endo M, Nakajima stem cell-like characteristics in small-cell lung cancer. Br J Cancer
T, Ohde Y, Takahashi T, Yamamoto N. Molecular profiling of small 2010;102:1636-44.
cell lung cancer in a Japanese cohort. Lung Cancer 2014;84:139-44. 86. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M,
80. Iwakawa R, Takenaka M, Kohno T, Shimada Y, Totoki Y, Shibata Westerdaal NA, Kvalheim G, Gaudernack G. Identification and
T, Tsuta K, Nishikawa R, Noguchi M, Sato-Otsubo A, Ogawa S, characterization of cells with cancer stem cell properties in human
Yokota J. Genome-wide identification of genes with amplification primary lung cancer cell lines. PLoS One 2013;8:e57020.
and/or fusion in small cell lung cancer. Genes Chromosomes Cancer 87. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A,
2013;52:802-16. Conticello C, Ruco L, Peschle C, De Maria R. Identification and
81. Peifer M, Fernandez-Cuesta L, Sos ML, George J, Seidel D, Kasper expansion of the tumorigenic lung cancer stem cell population. Cell
LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker Death Differ 2008;15:504-14.
M, Dahmen I, Muller C, Di Cerbo V, Schildhaus HU, Altmuller J, 88. Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y. Characterization of
Baessmann I, Becker C, de Wilde B, Vandesompele J, Bohm D, sphere-forming cells with stem-like properties from the small cell
Ansen S, Gabler F, Wilkening I, Heynck S, Heuckmann JM, Lu lung cancer cell line H446. Cancer Lett 2012;323:161-70.
X, Carter SL, Cibulskis K, Banerji S, Getz G, Park KS, Rauh D, 89. Roudi R, Korourian A, Shariftabrizi A, Madjd Z. Differential
Grutter C, Fischer M, Pasqualucci L, Wright G, Wainer Z, Russell expression of cancer stem cell markers ALDH1 and CD133 in
P, Petersen I, Chen Y, Stoelben E, Ludwig C, Schnabel P, Hoffmann various lung cancer subtypes. Cancer Invest 2015;33:294-302.
H, Muley T, Brockmann M, Engel-Riedel W, Muscarella LA, 90. Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl
Fazio VM, Groen H, Timens W, Sietsma H, Thunnissen E, Smit DM, Wang W, Forbes SJ, Gregory CD, Sethi T. CD133+ cancer
E, Heideman DA, Snijders PJ, Cappuzzo F, Ligorio C, Damiani stem-like cells in small cell lung cancer are highly tumorigenic and
S, Field J, Solberg S, Brustugun OT, Lund-Iversen M, Sanger J, chemoresistant but sensitive to a novel neuropeptide antagonist.
Clement JH, Soltermann A, Moch H, Weder W, Solomon B, Soria Cancer Res 2014;74:1554-65.
JC, Validire P, Besse B, Brambilla E, Brambilla C, Lantuejoul S, 91. Wang B, Yang H, Huang YZ, Yan RH, Liu FJ, Zhang JN. Biologic
Lorimier P, Schneider PM, Hallek M, Pao W, Meyerson M, Sage J, characteristics of the side population of human small cell lung
Shendure J, Schneider R, Buttner R, Wolf J, Nurnberg P, Perner S, cancer cell line H446. Chin J Cancer 2010;29:254-60.
Heukamp LC, Brindle PK, Haas S, Thomas RK. Integrative genome 92. Zhang Z, Zhou Y, Qian H, Shao G, Lu X, Chen Q, Sun X, Chen D, Yin
analyses identify key somatic driver mutations of small-cell lung R, Zhu H, Shao Q, Xu W. Stemness and inducing differentiation of
cancer. Nat Genet 2012;44:1104-10. small cell lung cancer NCI-H446 cells. Cell Death Dis 2013;4:e633.
82. Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, 93. Kolev VN, Wright QG, Vidal CM, Ring JE, Shapiro IM, Ricono
Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, Rivers J, Weaver DT, Padval MV, Pachter JA, Xu Q. PI3K/mTOR dual
290
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ August 17, 2016 ¦